ArticleEuropean urology open science2022

A Feasibility Study of the Therapeutic Response and Durability of Short-term Androgen-targeted Therapy in Early Prostate Cancer Managed with Surveillance: The Therapeutics in Active Prostate Surveillance (TAPS01) Study.

Tristan Barrett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.